NCT02784275View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 9, 2016

Primary Completion Date

May 3, 2017

Study Completion Date

May 17, 2017

Conditions
Diabetes Mellitus Type 2 in Obese
Interventions
DRUG

Cyclo-Z

DRUG

Placebo

Trial Locations (4)

33016

Hialeah

77095

Houston

77375

Tomball

90036

Los Angeles

All Listed Sponsors
lead

NovMetaPharma Co., Ltd.

INDUSTRY

NCT02784275 - A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes | Biotech Hunter | Biotech Hunter